Vogt Katharina, Netsch Christopher, Becker Benedikt, Oye Sebastian, Gross Andreas J, Rosenbaum Clemens M
Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany.
Front Surg. 2021 Mar 31;8:652958. doi: 10.3389/fsurg.2021.652958. eCollection 2021.
So far, it has not been described whether the perioperative course and the pathologic outcome of patients who undergo radical cystectomy (RC) with orthotopic bladder substitution differs if nerve sparing (NS) is performed or not. In all, there were 472 patients who underwent RC between 2012 and 2019 at our department. We performed a retrospective analysis of 116 patients who underwent RC with ileal neobladder. We analyzed perioperative complications according to the Clavien-Dindo classification system, as well as the pathological outcome. Of 116 patients, 68 (58.6%) underwent RC, and 48 (41.4%) underwent NS RC. Clavien-Dindo complications ≥3b occurred in 15 (12.9%) of all patients. Only infectious complications differed among the groups [NS RC: 25 patients (52.1%) vs. RC: 20 patients (29.4%); = 0.02]. There was no significant difference concerning tumor stage. Concomitant Cis was present in 24 patients (35.3%) of the RC group and in 27 patients (56.3%) of the NS RC group ( = 0.036). Nodal status and positive surgical margin status of the bladder tumor did not differ among the groups. In all, 42 of all male patients (45.7%) had an incidental prostatic carcinoma. Positive surgical margins concerning the prostate carcinoma occurred in six patients, with all cases in the RC group ( = 0.029). Our data suggest that performing NS during RC in carefully selected patients is a safe procedure and does not impair perioperative outcome. Pathological outcome of NS RC is comparable as well.
到目前为止,尚未有关于接受原位膀胱替代根治性膀胱切除术(RC)的患者,无论是否进行神经保留(NS),其围手术期过程和病理结果是否存在差异的描述。2012年至2019年期间,我院共有472例患者接受了RC手术。我们对116例行回肠新膀胱RC手术的患者进行了回顾性分析。我们根据Clavien-Dindo分类系统分析了围手术期并发症以及病理结果。116例患者中,68例(58.6%)接受了RC手术,48例(41.4%)接受了NS RC手术。所有患者中,Clavien-Dindo并发症≥3b级的有15例(12.9%)。仅感染性并发症在两组间存在差异[NS RC组:25例患者(52.1%) vs. RC组:20例患者(29.4%);P = 0.02]。肿瘤分期方面无显著差异。RC组24例患者(35.3%)和NS RC组27例患者(56.3%)存在同步化疗(P = 0.036)。膀胱肿瘤的淋巴结状态和手术切缘阳性状态在两组间无差异。所有男性患者中,共有42例(45.7%)患有偶发性前列腺癌。前列腺癌手术切缘阳性的有6例患者,均在RC组(P = 0.029)。我们的数据表明,在精心挑选的患者中,RC手术期间进行NS是一种安全的手术方式,不会影响围手术期结果。NS RC的病理结果也具有可比性。